In case you missed it: May 17 to May 21
It was a very busy week for the Contemporary Pediatrics team.
This week’s top articles included:
What parents think of virtual visits
Virtual visits with the doctor have become a fact of life for more families as a result of the pandemic. A new poll examines how parents feel about this change.
2021 evaluation and management coding update
A new evaluation and management coding system for outpatient visits was implemented earlier this year. This article details the nuances of the new system.
A pediatrician’s dilemma: Understanding, diagnosing, and treating antenatal hydronephrosis
Antenatal hydronephrosis (ANH), also referred to as urinary tract dilation, is one of the most confounding challenges to the practicing pediatrician. When dealing with newborns and children with ANH, pediatricians face understanding the significance of the degree of hydronephrosis, risk assessment, prenatal and postnatal management, and the use of prophylactic antibiotics.
Improving organ donation in pediatrics
Adult organ donation has risen over the past years, but declined in pediatrics. A study examined consent for pediatric organ donation.
Having "the talk" with teen patients
June 17th 2022A visit with a pediatric clinician is an ideal time to ensure that a teenager knows the correct information, has the opportunity to make certain contraceptive choices, and instill the knowledge that the pediatric office is a safe place to come for help.
Meet the Board: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI
May 20th 2022Contemporary Pediatrics sat down with one of our newest editorial advisory board members: Vivian P. Hernandez-Trujillo, MD, FAAP, FAAAAI, FACAAI to discuss what led to her career in medicine and what she thinks the future holds for pediatrics.
Study finds reduced CIN3+ risk from early HPV vaccination
April 17th 2024A recent study found that human papillomavirus vaccination when aged under 20 years, coupled with active surveillance for cervical intraepithelial neoplasia grade 2, significantly lowers the risk of cervical intraepithelial neoplasia grade 3 or cervical cancer.
